UPDATE: Citi Starts Amarin (AMRN) at Buy; Sees Favorable Risk/Reward Even if 'Going Alone' on Vascepa

November 27, 2012 6:13 AM EST Send to a Friend
(Updated - November 27, 2012 11:30 AM EST)

Amarin (Nasdaq: AMRN) is ticking higher amid Citi starting coverage on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login